What? what part don't you get? the $.066 in FY2010 earnings at $2B in sales? You know when you spend $400M more than you make you don't get earnings untill you make $400M. Elan does have to pay taxes someday and the EU rates suck big-time. Its Biotech and GSK will be a significant player in the MS market around FY08 and their are a more RA drugs coming to market than ELN has in its total pipeline. Well if you don't get it I quess its the water. Drink some good wine like a 1998 Frogsleap Merlot its priced about $50 Bottle.